Mergen.financeWest Pharmaceutical Services
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sept | Oct | Nov | Dec | Year |
|---|
| 2026 | ▼ 16.0% | ▲ 10.0% | ▼ 1.5% | ▲ 18.7% | ▲ 8.5% | ▲ 11.2% | ▼ 5.0% | 0.0% | ▲ 8.7% | ▲ 11.3% | ▼ 0.9% | ▲ 48.6% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ▼ 0.8% |
From our own closes, each month-end against the previous month-end. Colour saturates at ▲ 16.0%; an empty cell means no data, a dash means we declined to derive one.
Fiscal period: FY · 2025-12-31 (10-K) — annual data, not TTM · USD · Source: SEC EDGAR (public domain)
Balance-sheet lines and ratios (assets, equity, ROE, ROA, net margin, debt/equity) open on the paid plans. See the plans
Locked content: requires the Mergen plan
1 of 168 rows open
Data: Twelve Data · before August 2026, the Marketstack archive